DGAM
ABMD

Desjardins Global Asset Management’s Abiomed Inc ABMD Stock Holding History

Desjardins Global Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,234
Closed -$303K – 494
2022
Q3 		$303K Sell
1,234
-67
-5% -$18.1K 0.04% 289
2022
Q2 		$322K Hold
1,301
– – 0.04% 287
2022
Q1 		$430K Sell
1,301
-32
-2% -$9.85K 0.04% 276
2021
Q4 		$478K Buy
+1,333
New +$450K 0.04% 281

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Desjardins Global Asset Management's ABMD Position: Q4 2022 in Review

Desjardins Global Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,234 shares — an estimated $303K sold.

Desjardins Global Asset Management first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $478K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Desjardins Global Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Desjardins Global Asset Management sold 1,234 Abiomed Inc shares in Q4 2022, an estimated $303K.
  • Desjardins Global Asset Management first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
  • Desjardins Global Asset Management's Abiomed Inc position peaked at $478K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Desjardins Global Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.